CVS/$CVS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About CVS
CVS Health currently offers a diverse set of healthcare services, although it plans to split into two organizations in early 2028. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 26 million medical members. The acquisition of Oak Street Health added primary care services to the mix.
- Ticker
- $CVS
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 259,500
- Headquarters
- Woonsocket, United States
- Website
- www.cvshealth.com
CVS Metrics
BasicAdvanced
$110B
10.00
$8.58
0.58
$2.66
3.10%
Price and volume
Market cap
$110B
Beta
0.58
52-week high
$110.68
52-week low
$69.51
Average daily volume
11M
Dividend rate
$2.66
Financial strength
Current ratio
0.853
Quick ratio
0.612
Long term debt to equity
0.867
Total debt to equity
0.933
Dividend payout ratio (TTM)
31.01%
Interest coverage (TTM)
4.17%
Profitability
EBITDA (TTM)
17,294
Gross margin (TTM)
13.72%
Net profit margin (TTM)
2.64%
Operating margin (TTM)
3.05%
Effective tax rate (TTM)
8.85%
Revenue per employee (TTM)
$1,610,000
Management effectiveness
Return on assets (TTM)
3.11%
Return on equity (TTM)
14.36%
Valuation
Price to earnings (TTM)
10.002
Price to revenue (TTM)
0.262
Price to book
1.36
Price to tangible book (TTM)
-3.76
Price to free cash flow (TTM)
7.034
Free cash flow yield (TTM)
14.22%
Free cash flow per share (TTM)
12.2
Dividend yield (TTM)
3.10%
Forward dividend yield
3.10%
Growth
Revenue change (TTM)
6.76%
Earnings per share change (TTM)
2,214.05%
3-year revenue growth (CAGR)
6.46%
10-year revenue growth (CAGR)
9.25%
3-year earnings per share growth (CAGR)
8.83%
10-year earnings per share growth (CAGR)
6.28%
3-year dividend per share growth (CAGR)
4.00%
10-year dividend per share growth (CAGR)
5.05%
What the Analysts think about CVS
Analyst ratings (Buy, Hold, Sell) for CVS stock.
Analyst projections of the future price of CVS stock.
Bulls say / Bears say
Third-quarter revenue rose 5.4% and adjusted EPS increased to $2.09 from $1.60 a year earlier. CVS lifted its 2026 adjusted EPS floor to $8.20 and cash-flow forecast to at least $15.5 billion, signalling stronger near-term earnings and cash generation. (CVS Health)
Aetna’s medical benefit ratio improved to 91.3% from 92.8% a year earlier, while adjusted operating income in Health Care Benefits rose. CVS raised that segment’s 2026 outlook, supporting the case that its insurance margin recovery is progressing. (CVS Health)
CVS plans to separate its insurance, PBM and care businesses from its retail pharmacy operations by the first half of 2028. The two-company structure could give each business clearer strategic focus and accountability. (CVS Health)
The FTC settlement requires Caremark to change parts of its commercial offering, including passing rebates through to members, delinking some fees from drug list prices and changing pharmacy reimbursement. These rules could pressure PBM economics, even as they resolve the FTC’s case. (Federal Trade Commission)
CVS warned that medical cost trends remain elevated and that macroeconomic headwinds could weigh on results. That leaves uncertainty around how durable Aetna’s improving margins will be. (CVS Health)
Retail pharmacy revenue fell 2% in the third quarter, with CVS citing drug price reductions, new generic medicines and reimbursement pressure. Those headwinds could limit growth even though prescription volumes increased. (CVS Health)
Data summarised monthly by Lightyear AI. Last updated on 4 Nov 2026.
CVS Financial Performance
Revenues and expenses
CVS Earnings Performance
Company profitability
Upcoming events
No upcoming events
CVS News
AllArticlesVideos
Funds containing CVS
AllUSDEURGBP
Fund name | Fund size | $CVS weighting |
|---|---|---|
Invesco Health Care S&P US Select Sector$XLVS | $552M | 1.80% |
Invesco Health Care S&P US Select Sector£XLVP | $552M | 1.80% |
iShares S&P 500 Health Care Sector€IUHE | €134M | 1.66% |
iShares Dow Jones U.S. Select Dividend€EXX5 | €412M | 1.27% |
SPDR MSCI World Health Care$WHEA | $708M | 1.22% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.


